Lv1
60 积分 2024-02-07 加入
Appendicectomy versus switching to a JAK inhibitor in inducing remission in patients with active ulcerative colitis after biologic therapy failure (COSTA): 1-year results of a multicentre, prospective, cohort study
21天前
已完结
Human genetics guides the discovery of CARD9 inhibitors with anti-inflammatory activity
1个月前
已完结
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial
2个月前
已完结
Anti-TNF-associated immunogenicity: use a retroactive drug but a proactive approach
2个月前
已关闭
Assessment of the influence of Fc‐γ receptor polymorphisms on biologics' pharmacokinetics in Tunisian rheumatoid arthritis patients
2个月前
已完结
Clinical relevance of detecting anti-infliximab antibodies with a drug-tolerant assay: post hoc analysis of the TAXIT trial
3个月前
已完结
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases
3个月前
已完结
Pouchitis: pathophysiology and management
4个月前
已完结
Immunogenicity of Therapeutic Antibodies Used for Inflammatory Bowel Disease: Treatment and Clinical Considerations
4个月前
已完结
Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting
4个月前
已完结
皖公网安备34019202002308
